Mike Bandick

Mike Bandick joined G & S Research in 2006 and is vice president of client solutions for the company. Mr. Bandick is primarily responsible for strengthening G & S Research’s relationships with existing and prospective client companies. He is also a member of the company's executive committee.

Prior to joining G & S Research, Mr. Bandick was the director of marketing for Suros Surgical Systems (acquired by Hologic, Inc.), a rapidly growing medical device company. From 1991 to 2004, he held several domestic and global leadership roles with Eli Lilly and Company, most recently as global marketing director for Cymbalta®, Lilly’s successful antidepressant/ pain treatment. He also worked extensively with the Zyprexa® brand, Lilly’s $4 billion schizophrenia/ bipolar disorder medication.

He recently authored a feature article in MedAdNews on sales force effectiveness and has presented at several conferences, including The Pharma Market Research Event and the American Marketing Association (AMA).

Mr. Bandick graduated from Duke University’s MBA program and has an undergraduate degree from Cal Poly Pomona (California State University). He serves on the board of directors for the Indianapolis chapter of the Susan G. Komen Breast Cancer Foundation.